Talk to Alison

00 1 718 618 48 97

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, April 2013 (p9)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

241-280 of about 3 800 reports
Iran Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Iran Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: We continue viewing Iran as one of the less attractive regional industries. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian ...

  • Industries : Drug and Medication
  • Countries : Iran
Peru Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Peru Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Peru's large and growing population underpins the potential of its pharmaceutical industry , especially given the rising prevalence of non-communicable diseases. However, Peru remains listed ...

  • Industries : Drug and Medication
  • Countries : Peru
Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite an increasingly ageing population (consequently increasing burden of noncommunicable diseases), Hong Kong will only be moderately attractive to investors ...

  • Industries : Drug and Medication
  • Countries : China
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Indonesia is a high growth pharmaceutical industry driven by rising domestic consumption and government spending on healthcare. Having said this, the prevalence ...

  • Industries : Drug and Medication
  • Countries : Indonesia
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: South Africa is one of the most developed industry s in the region from a business environment and regulatory standpoint. However, vast income disparity within ...

  • Industries : Drug and Medication
  • Countries : South Africa
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Moldova's pharmaceutical industry recorded stronger growth in 2011, but its small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination fo ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
India Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

India Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: India's pharmaceutical industry is highly attractive to drugmakers but it also has several negative characteristics. Combined revenues of over-the-counter (OTC) ...

  • Industries : Drug and Medication
  • Countries : India
United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: New population data for 2011 show the size of the expatriate population in the United Arab Emirates (UAE) has been underappreciated. Population growth has fed ...

  • Industries : Drug and Medication
  • Countries : United Arab Emirates
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Venezuela's pharmaceutical market will face increasingly harsh pricing policy which is unlikely to tackle the persistent medicine shortage problem. President ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Bahrain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Bahrain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Bahrain is a developed pharmaceutical industry with patented drug spending accounting for over 83% of the total pharmaceutical expenditure in 2011. However, ...

  • Industries : Drug and Medication
  • Countries : Bahrain
Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Germany
Argentina Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Measured in local currency and in US dollars, the value of Argentina's pharmaceutical industry is expected to grow at double-digit rates over the five years to 2016, in large part due to inflationary ...

  • Industries : Drug and Medication
  • Countries : Argentina
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Belgium, much like most of the other regional industries, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical revenues because ...

  • Industries : Drug and Medication
  • Countries : Belgium
Kenya Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Historical underinvestment in the Kenyan healthcare segment and its high growth projection - driven by strong demographics, increased healthcare needs, longer life expectancy, increased healthcare ...

  • Industries : Drug and Medication
  • Countries : Kenya
Turkey Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: While the Turkish pharmaceutical market has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains ...

  • Industries : Drug and Medication
  • Countries : Turkey, United States
Australia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Australia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Given the country's increasingly ageing population and the consequential rise in noncommunicable diseases, Australia is a highly attractive place for multinational ...

  • Industries : Drug and Medication
  • Countries : Australia
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Mexico offers significant and improving opportunities for multinational pharmaceutical firms, especially in the outperforming generic medicine and improving ...

  • Industries : Drug and Medication
  • Countries : Mexico
Pakistan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Pakistan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The operational environment for drugmakers in Pakistan has worsened over the past year, partly as a result of the dissolution of the Ministry of Health (MoH) ...

  • Industries : Drug and Medication
  • Countries : Pakistan
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the strength of the UK's pharmaceutical manufacturing market is significant, the segment will face considerable challenges over the coming years. Economic ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
New Zealand Pharmaceuticals and Healthcare Report Q3 2013

New Zealand Pharmaceuticals and Healthcare Report Q3 2013

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Low growth potential in New Zealand's pharmaceutical market will attract risk-averse investors. However, we note that regulatory delays in funding new medicines ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Japan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Japan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The prospects for Japan's pharmaceutical industry over the medium term are very positive. The country has one of the largest pensionable populations, healthcare ...

  • Industries : Drug and Medication
  • Countries : Japan
Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Nigerian pharmaceutical industry continues to be seen as a risky proposition to multinationals. While the country's oil revenues are significant, income ...

  • Industries : Drug and Medication
  • Countries : Nigeria
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We stand by our negative projection for the Croatian pharmaceutical industry in 2012, on the back of the weakening economy and wide-ranging cost-containment ...

  • Industries : Drug and Medication
  • Countries : Croatia
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Qatar Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Qatar Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

BMI View: Following Qatar's decision to reintroduce controls on medicine prices in late 2011, we expect pharmaceutical price inflation to moderate. Consequently, industry growth rates in 2012 will be at ...

  • Industries : Drug and Medication
  • Countries : Qatar
Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Puerto Rico is struggling to retain its reputation as a pharmaceutical manufacturing hub, with a number of plants found to be in breach of regulations and standards over recent years. Additionally, ...

  • Industries : Drug and Medication
  • Countries : United States
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We continue to believe the Belarusian pharmaceutical industry has long-term potential due to the country's favourable geographic position, demographic profile ...

  • Industries : Drug and Medication
  • Countries : Belarus
Chile Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Chile Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Chile's pharmaceutical industry is expected to become an increasingly attractive proposition for multinational industry players as regulatory and intellectual ...

  • Industries : Drug and Medication
  • Countries : Chile
United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceutical market. This is in stark contrast to the late 1990s and early 2000s, when the business environment was ...

  • Industries : Drug and Medication
  • Countries : United States

Number Of Approvals Of Registration-drug_new Drug Certificate-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Export Amount-pharmaceuticals_chinese Patent Medicine-china-annual, In Usd (ten Thousands)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_new Drug Certificate And Production-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_imported Drug Re-registration-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_drug Filing-china-state Bureau-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Export Volume-pharmaceuticals_chinese Patent Medicine-china-annual, In Tonne (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_certificates And Production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Number Of Approvals Of Registration-drug_drug Supplementary-china-provincial Bureau-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

Ex-factory Price Indices Of Industrial Products-manufacture Of Medicines-china-yoy Growth-annual, In Preceding Year = 100

  • $ 250
  • Industry data
  • May 2013

Yearly, From 1986 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug and Medication

» Read our Company Profiles

70 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.